Chlorine in PDB 3s9s: Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist
Protein crystallography data
The structure of Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist, PDB code: 3s9s
was solved by
M.H.Lambert,
R.X.Xu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
61.30 /
2.55
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
56.086,
88.754,
122.605,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
22.4 /
28.4
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist
(pdb code 3s9s). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist, PDB code: 3s9s:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 3s9s
Go back to
Chlorine Binding Sites List in 3s9s
Chlorine binding site 1 out
of 4 in the Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1
b:51.1
occ:0.50
|
CL1
|
A:M0T1
|
0.0
|
51.1
|
0.5
|
CL1
|
A:M0T1
|
0.8
|
49.7
|
0.5
|
C13
|
A:M0T1
|
1.7
|
48.9
|
0.5
|
C13
|
A:M0T1
|
1.9
|
48.7
|
0.5
|
C14
|
A:M0T1
|
2.4
|
48.7
|
0.5
|
CL2
|
A:M0T1
|
2.4
|
50.3
|
0.5
|
C14
|
A:M0T1
|
2.7
|
48.8
|
0.5
|
C12
|
A:M0T1
|
2.7
|
48.1
|
0.5
|
CL2
|
A:M0T1
|
3.0
|
48.8
|
0.5
|
C12
|
A:M0T1
|
3.1
|
48.6
|
0.5
|
CG2
|
A:ILE281
|
3.6
|
55.6
|
1.0
|
C15
|
A:M0T1
|
3.8
|
47.9
|
0.5
|
CE
|
A:MET348
|
3.9
|
49.0
|
1.0
|
C11
|
A:M0T1
|
4.0
|
47.4
|
0.5
|
O
|
A:ILE281
|
4.0
|
55.6
|
1.0
|
C15
|
A:M0T1
|
4.0
|
47.6
|
0.5
|
CA
|
A:ILE281
|
4.1
|
57.0
|
1.0
|
SG
|
A:CYS285
|
4.2
|
52.6
|
1.0
|
C11
|
A:M0T1
|
4.3
|
47.2
|
0.5
|
SD
|
A:MET348
|
4.3
|
46.9
|
1.0
|
CB
|
A:ILE281
|
4.3
|
57.4
|
1.0
|
CD1
|
A:ILE262
|
4.4
|
68.0
|
1.0
|
C10
|
A:M0T1
|
4.5
|
47.3
|
0.5
|
C
|
A:ILE281
|
4.5
|
56.7
|
1.0
|
C10
|
A:M0T1
|
4.5
|
47.4
|
0.5
|
CG2
|
A:ILE341
|
4.5
|
47.6
|
1.0
|
CG2
|
A:ILE262
|
4.6
|
67.6
|
1.0
|
CG1
|
A:ILE262
|
4.6
|
67.6
|
1.0
|
CG1
|
A:ILE281
|
4.7
|
57.2
|
1.0
|
N
|
A:CYS285
|
4.7
|
51.6
|
1.0
|
CA
|
A:GLY284
|
4.9
|
52.9
|
1.0
|
CD1
|
A:ILE341
|
4.9
|
50.9
|
1.0
|
C
|
A:GLY284
|
5.0
|
52.1
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 3s9s
Go back to
Chlorine Binding Sites List in 3s9s
Chlorine binding site 2 out
of 4 in the Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1
b:49.7
occ:0.50
|
CL1
|
A:M0T1
|
0.0
|
49.7
|
0.5
|
CL1
|
A:M0T1
|
0.8
|
51.1
|
0.5
|
C13
|
A:M0T1
|
1.7
|
48.7
|
0.5
|
C13
|
A:M0T1
|
1.8
|
48.9
|
0.5
|
CL2
|
A:M0T1
|
2.3
|
48.8
|
0.5
|
C14
|
A:M0T1
|
2.3
|
48.8
|
0.5
|
C12
|
A:M0T1
|
2.7
|
48.6
|
0.5
|
C14
|
A:M0T1
|
2.7
|
48.7
|
0.5
|
C12
|
A:M0T1
|
3.0
|
48.1
|
0.5
|
CL2
|
A:M0T1
|
3.1
|
50.3
|
0.5
|
C15
|
A:M0T1
|
3.7
|
47.6
|
0.5
|
C11
|
A:M0T1
|
3.9
|
47.2
|
0.5
|
C15
|
A:M0T1
|
3.9
|
47.9
|
0.5
|
CG2
|
A:ILE262
|
4.0
|
67.6
|
1.0
|
O
|
A:ILE281
|
4.1
|
55.6
|
1.0
|
C11
|
A:M0T1
|
4.2
|
47.4
|
0.5
|
CD1
|
A:ILE262
|
4.2
|
68.0
|
1.0
|
CG2
|
A:ILE281
|
4.3
|
55.6
|
1.0
|
CG1
|
A:ILE262
|
4.3
|
67.6
|
1.0
|
SG
|
A:CYS285
|
4.3
|
52.6
|
1.0
|
N
|
A:CYS285
|
4.4
|
51.6
|
1.0
|
CA
|
A:GLY284
|
4.4
|
52.9
|
1.0
|
C10
|
A:M0T1
|
4.4
|
47.4
|
0.5
|
C10
|
A:M0T1
|
4.4
|
47.3
|
0.5
|
CG2
|
A:ILE341
|
4.5
|
47.6
|
1.0
|
CE
|
A:MET348
|
4.5
|
49.0
|
1.0
|
C
|
A:GLY284
|
4.5
|
52.1
|
1.0
|
CA
|
A:ILE281
|
4.5
|
57.0
|
1.0
|
CB
|
A:ILE262
|
4.7
|
68.4
|
1.0
|
CD1
|
A:ILE341
|
4.8
|
50.9
|
1.0
|
C
|
A:ILE281
|
4.8
|
56.7
|
1.0
|
CB
|
A:ILE341
|
4.8
|
48.8
|
1.0
|
CB
|
A:ILE281
|
4.9
|
57.4
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 3s9s
Go back to
Chlorine Binding Sites List in 3s9s
Chlorine binding site 3 out
of 4 in the Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1
b:48.8
occ:0.50
|
CL2
|
A:M0T1
|
0.0
|
48.8
|
0.5
|
C12
|
A:M0T1
|
1.5
|
48.6
|
0.5
|
C14
|
A:M0T1
|
1.7
|
48.8
|
0.5
|
C13
|
A:M0T1
|
2.1
|
48.7
|
0.5
|
CL1
|
A:M0T1
|
2.3
|
49.7
|
0.5
|
C13
|
A:M0T1
|
2.7
|
48.9
|
0.5
|
C15
|
A:M0T1
|
2.7
|
47.6
|
0.5
|
C11
|
A:M0T1
|
2.7
|
47.2
|
0.5
|
CL1
|
A:M0T1
|
3.0
|
51.1
|
0.5
|
C14
|
A:M0T1
|
3.4
|
48.7
|
0.5
|
O
|
A:HOH22
|
3.4
|
4.0
|
1.0
|
C
|
A:GLY284
|
3.6
|
52.1
|
1.0
|
O
|
A:GLY284
|
3.8
|
52.4
|
1.0
|
C10
|
A:M0T1
|
3.8
|
47.4
|
0.5
|
N
|
A:CYS285
|
3.9
|
51.6
|
1.0
|
C12
|
A:M0T1
|
3.9
|
48.1
|
0.5
|
C10
|
A:M0T1
|
4.0
|
47.3
|
0.5
|
CA
|
A:GLY284
|
4.0
|
52.9
|
1.0
|
CG2
|
A:ILE262
|
4.1
|
67.6
|
1.0
|
C15
|
A:M0T1
|
4.1
|
47.9
|
0.5
|
CA
|
A:CYS285
|
4.3
|
50.9
|
1.0
|
C11
|
A:M0T1
|
4.4
|
47.4
|
0.5
|
CB
|
A:ILE341
|
4.6
|
48.8
|
1.0
|
CG2
|
A:ILE341
|
4.6
|
47.6
|
1.0
|
CL2
|
A:M0T1
|
4.7
|
50.3
|
0.5
|
SG
|
A:CYS285
|
4.7
|
52.6
|
1.0
|
CB
|
A:ARG288
|
4.9
|
47.9
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 3s9s
Go back to
Chlorine Binding Sites List in 3s9s
Chlorine binding site 4 out
of 4 in the Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Ligand Binding Domain of Ppargamma Complexed with A Benzimidazole Partial Agonist within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1
b:50.3
occ:0.50
|
CL2
|
A:M0T1
|
0.0
|
50.3
|
0.5
|
C12
|
A:M0T1
|
1.4
|
48.1
|
0.5
|
C14
|
A:M0T1
|
1.7
|
48.7
|
0.5
|
C13
|
A:M0T1
|
2.1
|
48.9
|
0.5
|
CL1
|
A:M0T1
|
2.4
|
51.1
|
0.5
|
C11
|
A:M0T1
|
2.7
|
47.4
|
0.5
|
C15
|
A:M0T1
|
2.7
|
47.9
|
0.5
|
C13
|
A:M0T1
|
2.7
|
48.7
|
0.5
|
CL1
|
A:M0T1
|
3.1
|
49.7
|
0.5
|
SD
|
A:MET348
|
3.1
|
46.9
|
1.0
|
C14
|
A:M0T1
|
3.4
|
48.8
|
0.5
|
CG2
|
A:ILE281
|
3.4
|
55.6
|
1.0
|
C10
|
A:M0T1
|
3.8
|
47.3
|
0.5
|
CE
|
A:MET348
|
3.8
|
49.0
|
1.0
|
C10
|
A:M0T1
|
3.9
|
47.4
|
0.5
|
CD2
|
A:LEU353
|
3.9
|
46.6
|
1.0
|
C12
|
A:M0T1
|
4.0
|
48.6
|
0.5
|
SG
|
A:CYS285
|
4.1
|
52.6
|
1.0
|
C15
|
A:M0T1
|
4.1
|
47.6
|
0.5
|
CG2
|
A:ILE341
|
4.2
|
47.6
|
1.0
|
CG
|
A:MET348
|
4.4
|
47.2
|
1.0
|
CB
|
A:MET348
|
4.4
|
45.4
|
1.0
|
C11
|
A:M0T1
|
4.5
|
47.2
|
0.5
|
CD1
|
A:LEU353
|
4.6
|
46.1
|
1.0
|
CL2
|
A:M0T1
|
4.7
|
48.8
|
0.5
|
CG
|
A:LEU353
|
4.8
|
49.1
|
1.0
|
CB
|
A:ILE281
|
4.8
|
57.4
|
1.0
|
CG1
|
A:VAL339
|
4.9
|
46.6
|
1.0
|
|
Reference:
M.Sime,
A.C.Allan,
P.Chapman,
C.Fieldhouse,
G.M.Giblin,
M.P.Healy,
M.H.Lambert,
L.M.Leesnitzer,
A.Lewis,
R.V.Merrihew,
R.A.Rutter,
R.Sasse,
B.G.Shearer,
T.M.Wilson,
R.X.Xu,
D.J.Virley.
Discovery of GSK1997132B A Novel Centrally Penetrant Benzimidazole Ppargamma Partial Agonist. Bioorg.Med.Chem.Lett. V. 21 5568 2011.
ISSN: ISSN 0960-894X
PubMed: 21798739
DOI: 10.1016/J.BMCL.2011.06.088
Page generated: Sun Jul 21 04:15:57 2024
|